Joseph Catanzaro

May 22, 2026

Joseph Catanzaro rated QTTB as Outperform on May 22, 2026, setting a price target of 14. Shares have remained stable near 5.5, leaving the 14 target still in play.

May 15, 2026

On May 15, 2026, TNGX was given a Outperform rating by Joseph Catanzaro, with a target price of 30. The stock rallied 5.16% after the rating, narrowing the gap to the target of 30 and validating the bullish stance.

May 14, 2026

UPB received a Outperform rating from Joseph Catanzaro on May 14, 2026, aiming for 50. Price action was muted, as shares hovered around 8.46 despite the bullish outlook.

May 14, 2026

On May 14, 2026, Joseph Catanzaro published a Outperform outlook on AVTX, with a target of 45. Market action contradicted the Buy thesis, as shares slipped to 16.6.

May 12, 2026

Joseph Catanzaro on May 12, 2026 assigned ERAS a Outperform rating, with a price target of 26. The Buy call aligned well with market performance, producing a gain of 11.80%.

Apr 15, 2026

On Apr 15, 2026, Joseph Catanzaro reaffirmed CLYM with a Outperform rating, targeting 18. Market indecision has kept the 18 target in a holding pattern.

Mar 30, 2026

APGE was rated Outperform by Joseph Catanzaro on Mar 30, 2026, with a price objective of 110. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

Mar 23, 2026

On Mar 23, 2026, Joseph Catanzaro initiated coverage on CTMX with a Overweight rating and target of 12. The Buy call has yet to be validated as shares remain 8.24 away from the target.

Mar 02, 2026

Joseph Catanzaro issued a Outperform recommendation for EIKN on Mar 02, 2026, price target set at 26. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Jan 29, 2026

On Jan 29, 2026, NRIX was evaluated by Joseph Catanzaro, who gave a Overweight rating and target of 35. So far, the Buy call awaits clearer momentum, with shares flat at 17.53.

Jan 20, 2026

Joseph Catanzaro rated IBRX as Overweight on Jan 20, 2026, setting a price target of 7. The call has proven timely, with shares rising 19.44% toward the price target of 7.

Jan 13, 2026

On Jan 13, 2026, RVMD was given a Outperform rating by Joseph Catanzaro, with a target price of 143. The stock rallied 28.16% after the rating, narrowing the gap to the target of 143 and validating the bullish stance.

Dec 18, 2025

On Dec 18, 2025, Joseph Catanzaro published a Outperform outlook on SYRE, with a target of 53. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 74.32.

Dec 11, 2025

Joseph Catanzaro on Dec 11, 2025 assigned KYMR a Outperform rating, with a price target of 120. The call has struggled to gain traction, with shares losing 8.20%.

Oct 21, 2025

On Oct 21, 2025, Joseph Catanzaro reaffirmed CLDX with a Outperform rating, targeting 48. The recommendation was supported by strong follow-through as the stock rose from 30.58 to 30.58.

Feb 27, 2025

On Feb 27, 2025, Joseph Catanzaro initiated coverage on SDGR with a Overweight rating and target of 45. The Buy call has yet to be validated as shares remain 31.77 away from the target.

Feb 13, 2025

Joseph Catanzaro issued a Overweight recommendation for MRUS on Feb 13, 2025, price target set at 84. Investors following the Buy call captured upside momentum, with shares now at 90.

Feb 12, 2025

On Feb 12, 2025, GILD was evaluated by Joseph Catanzaro, who gave a Overweight rating and target of 110. This case illustrates how a timely bullish rating can translate into tangible gains of 26.32%.

Feb 12, 2025

Joseph Catanzaro rated EXEL as Overweight on Feb 12, 2025, setting a price target of 38. The call has proven timely, with shares rising 51.37% toward the price target of 38.

Jan 17, 2025

On Jan 17, 2025, KROS was given a Overweight rating by Joseph Catanzaro, with a target price of 15. The stock traded sideways with a 3.31% move, keeping the bullish thesis unresolved.

Dec 13, 2024

On Dec 13, 2024, Joseph Catanzaro published a Overweight outlook on CRDF, with a target of 10. Market action contradicted the Buy thesis, as shares slipped to 1.79.

Oct 07, 2024

Joseph Catanzaro on Oct 07, 2024 assigned IMTX a Overweight rating, with a price target of 19. The recommendation remains pending validation as shares consolidate around 11.06.

Sep 23, 2024

On Sep 23, 2024, Joseph Catanzaro reaffirmed BDTX with a Overweight rating, targeting 15. Shares slid 21.11% despite the recommendation, highlighting downside risks.

Aug 19, 2024

On Aug 19, 2024, Joseph Catanzaro initiated coverage on TSBX with a Overweight rating and target of 3.75. The Buy call has yet to be validated as shares remain 3.40 away from the target.

Aug 15, 2024

Joseph Catanzaro issued a Overweight recommendation for LENZ on Aug 15, 2024, price target set at 36. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Jul 08, 2024

On Jul 08, 2024, DAWN was evaluated by Joseph Catanzaro, who gave a Overweight rating and target of 40. This case illustrates how a timely bullish rating can translate into tangible gains of 45.47%.

Jun 14, 2024

Joseph Catanzaro rated OCUL as Overweight on Jun 14, 2024, setting a price target of 15. The call has proven timely, with shares rising 42.96% toward the price target of 15.

Apr 25, 2024

On Apr 25, 2024, ACRV was given a Overweight rating by Joseph Catanzaro, with a target price of 30. Despite the Buy call, shares fell from 1.79 to 1.79, challenging the optimistic stance.